An innovative implantable device and management platform to prevent chronic flui...
An innovative implantable device and management platform to prevent chronic fluid congestion
Pathologic fluid overload is a main clinical complication of congestive heart failure (CHF). CHF is a severe chronic disease affecting ~28 M people worldwide. Around 8 M of CHF patients are resistant to oral medications and underg...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ALLIANCE
Commercialising a smart cardiac implant platform for the tre...
4M€
Cerrado
2ND-CHANCE
Implantable sensors and ultrasonic data link with triggered...
3M€
Cerrado
CPP2021-009139
Concentrador Universal Asistido por Tecnología de Recomendac...
763K€
Cerrado
DVD-E
DVD-readable opto-electrochemical Lab-on-a-Disc as small-fac...
278K€
Cerrado
Contraband
ContraBand: the only heart failure medical device that is pl...
4M€
Cerrado
Duración del proyecto: 48 meses
Fecha Inicio: 2023-07-17
Fecha Fin: 2027-07-31
Líder del proyecto
PARAGATE MEDICAL LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
13M€
Descripción del proyecto
Pathologic fluid overload is a main clinical complication of congestive heart failure (CHF). CHF is a severe chronic disease affecting ~28 M people worldwide. Around 8 M of CHF patients are resistant to oral medications and undergo frequent hospitalizations to remove extra fluids with aggressive acute treatments, all carrying severe complications. None of these treatments can prevent fluid accumulation. The Israeli SME Paragate Medical has developed FILBERT, a unique implantable peritoneal ultrafiltration system for diuretic resistant CHF patients. It enables 24/7 monitoring and gentle draining of extra fluids in the urinary system, preventing their accumulation. A remote treatment management platform allows physicians to continuously control patients’ conditions and timely adjust therapy to prevent fluid accumulation. FILBERT shifts the paradigm of fluid congestion care from the hospital to the home, improving patients’ quality of life and saving billions to healthcare systems.